Study identity card

M-BOOST-FR

France
Share
  • Disease: Mpox, Sexually transmitted infection
  • Study type: Observational Cohort Study, Prevention
  • Study type descriptors: Prospective, Single centre
  • Objective: To evaluate the long-term immunogenicity and safety of a booster dose of MVA-BN vaccine
  • Number of participants enrolled: Enrollment ongoing
  • Study enrolling from to
  • Study includes follow-up for 2 years

Study Data

  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Serum
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Other information

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to